News Release: EPS Corporation(4282 TSE 1st section)
July 23, 2013

Notice of the acquisition of Gleneagles CRC Pte Ltd shares (as a wholly-owned subsidiary)
We would like to announce that on July 23, 2013, we signed a purchase agreement to acquire (as a wholly-ownedsubsidiary) shares in Gleneagles CRC Pte Ltd (GCRC), headquartered in Singapore, from Parkway Holdings Limited andMITSUI & CO., LTD.
1. Reason for the acquisition of sharesWith regards to our overseas CRO operation, in order to respond to the globalization of pharmaceutical companies,business activities have been carried out across the Asian region, in China, Hong Kong, Taiwan, Korea and Singapore, withGlobal Research Company, our in-house company, as the mainstay.
Meanwhile, GCRC is headquartered in Singapore, with bases in the Philippines, China, Australia, Thailand, Vietnam,Indonesia, South Korea, Malaysia and India. They support global pharmaceutical companies’ clinical trials in the AsiaPacific region. The parent company of GCRC is Parkway Holdings Limited which holds 51% of GCRC shares, and ownsand operates hospitals and medical-related businesses in the Asian region through its subsidiary, while MITSUI & CO.,LTD. holds 49%.
With the expansion of regional operations through this share acquisition as well as our mutually-complementary
customer bases, we will further strengthen our framework in the Asia-Pacific region. This will expand our business andfurther advance our group’s one-stop service in responding to the ongoing diversification and sophistication of ourcustomers’ needs.
In addition, in collaboration with MITSUI & CO., LTD. from whom we are to receive the share transfer, we haveintended to consider plans including the business deployments that anticipate the needs of pharmaceutical companies in theAsia-Pacific region.
2. Overview of the transferred subsidiary (Gleneagles CRC Pte Ltd)
(1)

Name

Gleneagles CRC Pte Ltd (GCRC)(2)

Address

80 Robinson Road #02-00 Singapore 068898(4)

Name & Title ofRepresentative
Business Activity(5)

CapitalSG$7,191,827 (approx. JPY 569 million)(6)

Date Established
Major Shareholders &Ownership Ratio

October 21, 1999
Parkway Holdings Limited 51% (510,000 shares),
MITSUI & CO., LTD. 49% (490,000 shares)
CapitalNo capital relationships that should be noted

(3)

(7)

(8)
(9)

Lim Cheok Peng, Chairman
Contract Research Organization

Relationship between thiscompany and our company

Personnel

No personnel relationships that should be noted

Business

Transaction of services related to clinical trials

Financial position and operating results of the past three years

Fiscal YearEnding December 2009

Ending December 2010

Ending December 2011

Consolidated net assets(762,056) thousand yen

554,446 thousand yen

495,692 thousand yen

Consolidated total assets

310,481 thousand yen

863,918 thousand yen

868,729 thousand yen

Consolidated net sales

646,817 thousand yen591,896 thousand yen

622,486 thousand yen

1,362 thousand yen(6,727) thousand yen(55,370) thousand yen

580 thousand yen(7,983) thousand yen(56,715) thousand yen

Consolidated ordinary income
Consolidated net income

Note: At an exchange rate of SG$1＝JPY79.16.
Note: Financial position and business results for the fiscal year December 2012 are undisclosed because the audit is not completed.

13. Overview of the counterparties in the share acquisition
(1)

Name

Parkway Holdings Limited(2)

Address

111 Somerset Road, #15-01 Triple One Somerset, Singapore 238164(3)Name & Title ofRepresentative

Tan See Leng, Director(4)

Business Activity

Shareholding(5)

Consolidated net assets

Undisclosed(6)Consolidated total assets

Undisclosed(7)(8)

Major Shareholders &Ownership Ratio

Parkway Pantai Limited 100%
CapitalNo capital relationships that should be noted

Relationship between

Personnel

No personnel relationships that should be noted

this company andBusinessNo business relationships that should be noted

our company

Status of

Not applicable

related parties(1)

NameMITSUI & CO., LTD.

(2)

Address

1-2-1 Otemachi, Chiyoda-ku, Tokyo, Japan(3)

Name & Title ofRepresentative

Masami Iijima, President and Chief Executive Officer
Utilizing the global operating locations, network and information resources, thecompany are multilaterally pursuing business that ranges from product sales,
worldwide logistics and financing, through to the development of major(4)

Business Activity

international infrastructure and other projects in the following fields: Iron & Steel
Products, Mineral & Metal Resources, Infrastructure Projects, Integrated
Transportation Systems, Chemicals, Energy, Food Resources, Food Products &Services, Consumer Services, Innovation & Corporate Development Business.

(5)

Consolidated net assets

3,440,104 million yen (as of March 31, 2013)(6)

Consolidated total assets

10,324,581 million yen (as of March 31, 2013)

Major Shareholders &The Master Trust Bank of Japan, Ltd. (Trust account) 8.22%

Ownership Ratio

Japan Trustee Services Bank, Ltd. (Trust account) 5.87%

(7)

(8)

CapitalNo capital relationships that should be noted

Relationship between

Personnel

No personnel relationships that should be noted

this company andBusinessTransaction of services related to clinical trials

our company

Status ofNot applicablerelated parties
4. Number of shares acquired, acquisition cost, and status of shares held before and after acquisition
(1)

(2)

(3)

Number of shares held
before transfer
Number of sharesacquired-shares(Voting rights: 0%)1,000,000 shares(Percentage of shares issued: 100%)
Acquisition price: There is a non-disclosure agreement between the parties.

Number of shares held

1,000,000 shares

after transfer(Voting rights: 100%)2

5. Schedule(1)

Resolution

July 23, 2013

(2)

Transfer of shares

July 30, 2013 (planned)

6. Future outlook
Although there are plans to position the company as a subsidiary in our consolidated financial statements, the impact on
our consolidated profit in the near term remains minimal. In the future, if an impact on performance is foreseen, a timely
notification will be issued when it is confirmed.

3